Company news
NovaBridge Biosciences news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Visara Announces First Patient Dosed in ASCEND Phase 2b Trial of VIS-101 in Wet AMD
November 18, 2026
NovaBridge Biosciences to Participate in Upcoming Investor Conferences
November 9, 2026
NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer
October 28, 2026
NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
October 25, 2026
Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia
October 20, 2026
Calls
The 5 newest of 8 calls. Every call is listed under its year.
- NovaBridge Biosciences (NASDAQ:NBP) Q2 2026 Earnings Call
Aug 20, 2026
Transcript - NovaBridge Biosciences (NASDAQ:NBP) Q2 2024 Earnings Call
Aug 28, 2024
Transcript - NovaBridge Biosciences (NASDAQ:NBP) Q2 2023 Earnings Call
Aug 17, 2023
Transcript - NovaBridge Biosciences (NASDAQ:NBP) Q4 2022 Earnings Call
Mar 31, 2023
Transcript - NovaBridge Biosciences (NASDAQ:NBP) Q2 2022 Earnings Call
Aug 30, 2022
Transcript
Decks
The 5 newest of 21 decks. Every deck is listed under its year.
- Investor Presentation (August 2026)
Investor deck · 20 slides · August 2026
- Investor Presentation (April 2026)
Investor deck · 43 slides · Apr 7, 2026
- Technical Presentation (March 2026)
Technical · 34 slides · Mar 9, 2026
- Investor Presentation (February 2026)
Investor deck · 45 slides · Feb 6, 2026
- Investor Presentation (January 2026)
Investor deck · 51 slides · Jan 6, 2026